Negative temperature sensitive hydrogels in controlled drug delivery

PVP/PNIPAAm copolymers exhibit a temperature sensitive nature that makes them an attractive candidate for controlled drug delivery devices. Diclofenac sodium was added to the monomeric mixture, which included an initiator and crosslinking agent (where appropriate), prior to UV photopolymerisation. It was found that the xerogels retained similar properties as the original samples (not containing drug) at lower levels of drug integration. In all cases, drug dissolution analysis showed that the active agent was released at a slower rate at temperatures above the Lower Critical Solution Temperature (LCST). Interestingly, the drug release trends were almost identical for both the physically and chemically crosslinked hydrogels, when the decrease in transition temperature caused by the incorporated crosslinking agent is taken into consideration. It is believed that both types of copolymers reached a constant maximum swollen weight at a set of temperatures above their transition temperatures. When this swollen plateau is attained, the hydrophilic-hydrophobic interactions are balanced, thus the gel does not swell or shrink further and the drug diffuses out at a constant rate.